Advertisement
Advertisement
U.S. markets close in 3 hours 1 minute
Advertisement
Advertisement
Advertisement
Advertisement

Lannett Company, Inc. (LCI)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.4961-0.0139 (-2.73%)
As of 12:58PM EDT. Market open.
Advertisement
Sign in to post a message.
  • D
    DZEE
    Volume building up!!
  • K
    K
    Feb and Mar 2022: Insiders have bought about 3.7M shares.
  • T
    THT
    CC: After a heroic work due to surprising competitive pressure this quarter our sales dropped to $50mln, better than we expected. We are proud to be a US based generic drugs company actively promoting Chinese and Mexican products.
  • C
    Colin
    reading between the lines....cash position went up a touch.....latest results align with guidance...what is the status of Advair?.....what new products are in the near term pipeline? not fair to tease....if this one is a goner....then why is the inner circle not bailing?
  • A
    American
    It’s crunch time. I don’t think we’re going bk so I’m buying. It’s one of the very few domestic companies still manufactured here in USA.
  • A
    American
    Let’s get positive here. I’ve traded this stock for a couple years and I have a sense that it’s still a good deal. Maybe even back over a dollar soon
    Bullish
  • Y
    Yahoo Finance Insights
    Lannett Company reached a 52 Week low at 0.54
  • Y
    Yahoo Finance Insights
    Lannett Company reached a 52 Week low at 0.57
  • K
    K
    Only miracle would save this company. Otherwise, it is over and time to turn the lights off and close the doors.
  • K
    K
    No sign of light at the end of tunnel. Bottom line, slow death is written on the wall.
  • A
    A. Luis
    I was resigned to the idea LCI would be in purgatory (delisted) and on the pink sheets until positive results from the launch of garline. Now I’m hopeful again things are looking brighter with todays bounce. Hopefully it’s not a dead cat bounce. I still believe in Tim Crew.
  • M
    Michael
    Let's see where the next earnings takes us
  • A
    Abraham
    (LABP) $0.90 trading 50% UNDER cash and has HUGE late stage pipeline --IPO was at $16 last year = HUGE Reboundplay here with a tgt of 10++ dollars ...GL
    https://static.seekingalpha.com/uploads/2021/1/29/saupload_FVuhKb92aIl9d8NORFvgJlzyS61Yroic6x4Yh9BdxYKkAfBq3IKb2C4Nvot2in4BSQvktROM0ZCo68kHzoyox1g3WClOKDTL0zu3-7Fq-yF4Dd-HMFrRo9t-pqWW8L1S6vKiMrVh.jpeg

    ##
  • C
    Chuck
    Wonder if Elon Musk will buy LCI with some money that fell in between the cushions in his sofa.
  • M
    Michael
    massive turnaround give it 2 years
  • Y
    Yahoo Finance Insights
    Lannett Company reached a 52 Week low at 0.70
  • A
    Anonymous
    It's been years since I invested in LCI. Four years ago, the management team did an excellent job navigating the loss of LEVO. They managed the debt the best they could and made some good decisions on lowering costs. Since then, the generics market has become a much harder place to make margin. I do have faith that this management team can again navigate through these troubled times. It may take time but I am investing in the team. The risk of losing the entire investment is real however, I feel the many years of business in this area will allow them to find a way though. Looking forward to the day we are above $5/share and climbing.
  • L
    LU
    they will receive a de-list notice very soon as their market cap has been under 50mil for a while, you are warned
  • A
    Anonymous
    I'm absolutely amazed that people don't see the value in LCI. Raymond James just noted -
    1) LCI's mgmt. projects adjusted EDBITDA for fiscal 2020 "significantly ahead of Street estimates".
    2) The company "plans to launch another 15-17 products by the end of fiscal 2019. These would mostly be internally developed products with equally high margins and a market value exceeding $5 billion".

    My Analysis:
    1) LCI only has 38.95M shares outstanding. If the mkt value exceeds $5B, then the value of these products will exceed $128/share (5,000M / 38.95M shares).
    2) LCI is only selling @ $5/share.

    My Conclusion:
    Assuming the article did not contain a typo for the $5B, then this stock will be a real home run for longs. I just bought more shares and will wait out all the current selling. If you compute the present value of $128/share 2 years out @ 10% growth rate, you'll come up with $105/share in today's dollars, which is 21x today's share price. The short position of 16.78M shares alone will take 9.7 days to cover based on 16.78M shares / 1.729M share avg daily volume.

    LCI today is a value stock that trades with Price/Book = 0.61 and earned $60M or $1.54/share for Q1 2019 (qtr ending 09/2018) after backing out the Goodwill and Intangible Assets that were expensed in the quarter. The company will likely become a growth stock by Yr-End 2019 that will trade @ several times book value.
    Good luck with your investing.

    Is there something I'm missing here?
  • b
    bipin
    biosimilar insulin clinical trial start news
Advertisement
Advertisement